Patents Assigned to Yeda Research Development Co., Ltd.
  • Patent number: 6844314
    Abstract: Methods are provided for treating injury to or disease of the central or peripheral nervous system. In one embodiment, treatment is effected by administering activated T cells that recognize an antigen of Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration within the nervous system. In another embodiment, treatment involves administering Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration in the nervous system, either the central nervous system or the peripheral nervous system. The activated T cells, which have been activated by the presence of Cop 1 or a Cop 1-related peptide or polypeptide, can be administered alone or in combination with Cop 1 or a Cop 1-related peptide or polypeptide.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: January 18, 2005
    Assignee: Yeda Research Development Co., Ltd.
    Inventors: Michal Eisenbach-Schwartz, Irun R. Cohen, Michael Sela, Eti Yoles, Jonathan Kipnis